[
  {
    "objectID": "pages/publications.html",
    "href": "pages/publications.html",
    "title": "Publications",
    "section": "",
    "text": "Semiconducting artificial dendritic cells with biocatalytic and radiosensitive iron centers to eradicate radioresistant squamous cell carcinoma. DOI: 10.1016/j.celbio.2025.100277 (2025)\nCharacterizing the impact of sarcopenia on treatment response and survival in previously treated recurrent or metastatic nasopharyngeal carcinoma: Insights from a secondary analysis of the KL-A167 randomized trial.. DOI: 10.1200/jco.2024.42.16_suppl.6046 (2024)\nLiquid‒liquid phase separation: roles and implications in future cancer treatment. DOI: 10.7150/ijbs.81521 (2023)\nPrevalence and Prognostic Significance of Malnutrition in Patients with Brain Metastasis. DOI: 10.1158/1055-9965.epi-22-0918 (2023)\nAbstract 5562: Prevalence and prognostic significance of malnutrition in patients with brain metastasis. DOI: 10.1158/1538-7445.am2023-5562 (2023)\nNasopharyngeal Carcinoma: Clinical Achievements and Considerations Among Treatment Options. DOI: 10.3389/fonc.2021.635737 (2021)\nAssociation between fish oil supplementation and cancer risk according to fatty fish consumption: A large prospective population‐based cohort study using UK Biobank. DOI: 10.1002/ijc.33819 (2021)\nComparative efficacy and safety of immunotherapy in the first-line treatment of metastatic renal cell carcinoma: a systematic review and network meta-analysis. DOI: 10.21037/apm-20-1884 (2021)\nRadiomics-based prediction of survival in patients with head and neck squamous cell carcinoma based on pre- and post-treatment 18F-PET/CT. DOI: 10.18632/aging.103508 (2020)\nMolecular classification and immunologic characteristics of immunoreactive high-grade serous ovarian cancer. DOI: 10.1111/jcmm.15441 (2020)"
  },
  {
    "objectID": "pages/publications.html#selected-first-author",
    "href": "pages/publications.html#selected-first-author",
    "title": "Publications",
    "section": "",
    "text": "Semiconducting artificial dendritic cells with biocatalytic and radiosensitive iron centers to eradicate radioresistant squamous cell carcinoma. DOI: 10.1016/j.celbio.2025.100277 (2025)\nCharacterizing the impact of sarcopenia on treatment response and survival in previously treated recurrent or metastatic nasopharyngeal carcinoma: Insights from a secondary analysis of the KL-A167 randomized trial.. DOI: 10.1200/jco.2024.42.16_suppl.6046 (2024)\nLiquid‒liquid phase separation: roles and implications in future cancer treatment. DOI: 10.7150/ijbs.81521 (2023)\nPrevalence and Prognostic Significance of Malnutrition in Patients with Brain Metastasis. DOI: 10.1158/1055-9965.epi-22-0918 (2023)\nAbstract 5562: Prevalence and prognostic significance of malnutrition in patients with brain metastasis. DOI: 10.1158/1538-7445.am2023-5562 (2023)\nNasopharyngeal Carcinoma: Clinical Achievements and Considerations Among Treatment Options. DOI: 10.3389/fonc.2021.635737 (2021)\nAssociation between fish oil supplementation and cancer risk according to fatty fish consumption: A large prospective population‐based cohort study using UK Biobank. DOI: 10.1002/ijc.33819 (2021)\nComparative efficacy and safety of immunotherapy in the first-line treatment of metastatic renal cell carcinoma: a systematic review and network meta-analysis. DOI: 10.21037/apm-20-1884 (2021)\nRadiomics-based prediction of survival in patients with head and neck squamous cell carcinoma based on pre- and post-treatment 18F-PET/CT. DOI: 10.18632/aging.103508 (2020)\nMolecular classification and immunologic characteristics of immunoreactive high-grade serous ovarian cancer. DOI: 10.1111/jcmm.15441 (2020)"
  },
  {
    "objectID": "pages/publications.html#profiles",
    "href": "pages/publications.html#profiles",
    "title": "Publications",
    "section": "Profiles",
    "text": "Profiles\n\nORCID: https://orcid.org/0000-0002-4848-4951\nPubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Liu+Zheran%5BAuthor%5D"
  },
  {
    "objectID": "pages/orcid.html",
    "href": "pages/orcid.html",
    "title": "ORCID",
    "section": "",
    "text": "ORCID: https://orcid.org/0000-0002-4848-4951\n\nIf you connect ORCID to your publication list (or export your works), we can render a full publications page automatically."
  },
  {
    "objectID": "pages/contact.html",
    "href": "pages/contact.html",
    "title": "Contact",
    "section": "",
    "text": "ORCID: https://orcid.org/0000-0002-4848-4951\nPubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Liu+Zheran%5BAuthor%5D\nGitHub: https://github.com/ZEN-LIU-1\nEmail: zeno.liu@outlook.com"
  },
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "ZHERAN LIU",
    "section": "",
    "text": "I am a physician–scientist and postdoctoral researcher based at West China Hospital (Sichuan University). I received my MSc/PhD training in oncology at West China Hospital and my bachelor’s degree in Clinical Medicine from Nanchang University.\nMy work focuses on translational cancer research, especially the integration of clinical data with omics/bioinformatics to generate actionable insights."
  },
  {
    "objectID": "index.html#about",
    "href": "index.html#about",
    "title": "ZHERAN LIU",
    "section": "",
    "text": "I am a physician–scientist and postdoctoral researcher based at West China Hospital (Sichuan University). I received my MSc/PhD training in oncology at West China Hospital and my bachelor’s degree in Clinical Medicine from Nanchang University.\nMy work focuses on translational cancer research, especially the integration of clinical data with omics/bioinformatics to generate actionable insights."
  },
  {
    "objectID": "index.html#focus-areas",
    "href": "index.html#focus-areas",
    "title": "ZHERAN LIU",
    "section": "Focus areas",
    "text": "Focus areas\n\nCancer bioinformatics (bulk & single-cell; multi-omics)\nTranslational studies and reproducible analysis pipelines\nClinically grounded collaboration"
  },
  {
    "objectID": "pages/cv.html",
    "href": "pages/cv.html",
    "title": "CV",
    "section": "",
    "text": "Zheran Liu (刘哲然)\nPostdoctoral Researcher & Physician, Cancer Center, West China Hospital (Sichuan University)\nEmail: mailto:zeno.liu@outlook.com\nORCID: https://orcid.org/0000-0002-4848-4951\nPubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Liu+Zheran%5BAuthor%5D"
  },
  {
    "objectID": "pages/cv.html#education",
    "href": "pages/cv.html#education",
    "title": "CV",
    "section": "Education",
    "text": "Education\n\nPhD/MSc (Oncology; MD–PhD track) — West China School of Medicine / West China Hospital, Sichuan University, China (2019.09–2025.06)\n\nChina Association for Science and Technology (CAST) Young Talent Support Program (PhD track)\nSupervisor: Prof. Xingchen Peng\nHonors/Scholarships (selected): National Scholarship (MOE, China); Abbott Medical Nutrition Scholarship; Daiichi Sankyo Scholarship; Outstanding Graduate Student; Outstanding Graduate\n\nBMed (Clinical Medicine) + Sino‑UK Joint Program (Clinical Medicine & Biomedical Sciences) — Nanchang University, China (2014.09–2019.06)\n\nDual-degree track (Nanchang University × Queen Mary University of London)\nCET‑6: 552"
  },
  {
    "objectID": "pages/cv.html#appointments",
    "href": "pages/cv.html#appointments",
    "title": "CV",
    "section": "Appointments",
    "text": "Appointments\n\nPostdoctoral Researcher & Physician — Cancer Center, West China Hospital (Sichuan University), China (2025.07–present)"
  },
  {
    "objectID": "pages/cv.html#research-interests",
    "href": "pages/cv.html#research-interests",
    "title": "CV",
    "section": "Research interests",
    "text": "Research interests\n\nOncology and cancer bioinformatics\nSequencing / multi‑omics analysis (bulk & single‑cell)\nTranslational research and clinical data integration"
  },
  {
    "objectID": "pages/cv.html#publications-summary",
    "href": "pages/cv.html#publications-summary",
    "title": "CV",
    "section": "Publications (summary)",
    "text": "Publications (summary)\n\nUpdated automatically from OpenAlex using ORCID (0000-0002-4848-4951) on 2026‑02‑04.\n\n\nTotal publications (OpenAlex matched): 157\nH‑index (computed from OpenAlex cited_by_count): 14\nTotal citations (OpenAlex): 775\n\n\nNote: counts can differ from Google Scholar/PubMed due to author disambiguation and indexing coverage."
  },
  {
    "objectID": "pages/cv.html#representative-publications-first-cofirst",
    "href": "pages/cv.html#representative-publications-first-cofirst",
    "title": "CV",
    "section": "Representative publications (first / co‑first)",
    "text": "Representative publications (first / co‑first)\n\nLiu Z. Liquid–liquid phase separation: roles and implications in future cancer treatment. Int J Biol Sci. 2023;19(13):4139–4156. doi:10.7150/ijbs.81521\nLiu Z. Association between fish oil supplementation and cancer risk according to fatty fish consumption: a large prospective cohort study using UK Biobank. Int J Cancer. 2022;150(4):562–571.\nLiu Z. Associations of sleep and circadian phenotypes with COVID‑19 susceptibility and hospitalization: UK Biobank observational cohort + two‑sample Mendelian randomization. Sleep. 2022;45(6):zsac003.\nZhao Y, Liu Z. Biomimetic Hierarchical Construction of Anti‑Tumor Polyoxopalladates for Cancer Therapy. Angew Chem Int Ed. 2025;64(23):e202505564.\n\n\nFull list: see PubMed link above."
  },
  {
    "objectID": "pages/cv.html#patents-filed-selected",
    "href": "pages/cv.html#patents-filed-selected",
    "title": "CV",
    "section": "Patents (filed; selected)",
    "text": "Patents (filed; selected)\n\nUse of mesenchymal stem cell–derived exosomes for treating radiation‑induced skin injury (202410662238.4)\nRadioresistant head and neck squamous cell carcinoma cell line: construction and applications (202410790223.6)\nRadioresistant mouse oral squamous cell carcinoma cell line: construction and applications (202410790222.1)\nUse of SPOP protein for hepatocellular carcinoma therapeutics (202410892129.1)"
  },
  {
    "objectID": "pages/cv.html#grants-projects",
    "href": "pages/cv.html#grants-projects",
    "title": "CV",
    "section": "Grants & projects",
    "text": "Grants & projects\n\nPI — Sichuan Provincial Department of Science and Technology, MZGC20230020: Prognostic model for brain metastasis based on hematological markers (2023‑06‑01 to 2024‑06‑01), 20,000 RMB\nKey participant (lead analyst) — Central Government‑Guided Local S&T Development, 2024ZYD0054: CAF‑mediated EGFR‑TKI resistance in HNSCC (2024‑09‑01 to 2025‑08‑31), 300,000 RMB\nKey participant (lead analyst) — Sichuan International/HK/Macao/Taiwan S&T Collaboration, 2025YFHZ0087: AI‑driven neoantigen prediction & mRNA vaccine development for HNSCC (2025‑01‑01 to 2025‑12‑31), 200,000 RMB\nParticipant — National Key R&D Program of China, 2021YFE0206600: EBV‑targeted mRNA vaccine for nasopharyngeal carcinoma, 1,600,000 RMB (ongoing)"
  },
  {
    "objectID": "pages/cv.html#academic-services",
    "href": "pages/cv.html#academic-services",
    "title": "CV",
    "section": "Academic services",
    "text": "Academic services\n\nEditorial Board Member: BMC Cancer\nGuest Editor: Frontiers in Immunology\nReviewer: The BMJ, iMeta\nMemberships: AACR, Chinese Anti‑Cancer Association\nCommittee roles (selected): Sichuan Medical Communication Society (Cancer Prevention & Control Branch); Chengdu Anti‑Cancer Association (Cancer Rehabilitation)"
  },
  {
    "objectID": "pages/cv.html#training-international-experience",
    "href": "pages/cv.html#training-international-experience",
    "title": "CV",
    "section": "Training & international experience",
    "text": "Training & international experience\n\nASCO Annual Meeting (Chicago), Poster (2024; No. 6046)\nAACR Annual Meeting (Orlando), Poster (2023; No. 5562)\nHarvard & Johns Hopkins Medical School Graduate Training Program (2020)\nQueen Mary University of London, Summer exchange (2016)"
  },
  {
    "objectID": "pages/cv.html#skills",
    "href": "pages/cv.html#skills",
    "title": "CV",
    "section": "Skills",
    "text": "Skills\n\nBioinformatics / data analysis: extensive experience in single‑cell and transcriptomics analysis; clinical research statistics; data mining and visualization in R\nResearch: end‑to‑end experience across basic, translational, and clinical oncology research\nGrant writing / project operations: protocol writing, project registration & submission, statistical analysis"
  },
  {
    "objectID": "pages/cv.html#licenses-certifications",
    "href": "pages/cv.html#licenses-certifications",
    "title": "CV",
    "section": "Licenses & certifications",
    "text": "Licenses & certifications\n\nPhysician License (China)\nGCP Certification"
  },
  {
    "objectID": "pages/projects.html",
    "href": "pages/projects.html",
    "title": "Research",
    "section": "",
    "text": "My work focuses on head and neck squamous cell carcinoma (HNSCC), with an emphasis on multi-omics and single-cell analysis to answer clinically relevant questions."
  },
  {
    "objectID": "pages/projects.html#focus",
    "href": "pages/projects.html#focus",
    "title": "Research",
    "section": "",
    "text": "My work focuses on head and neck squamous cell carcinoma (HNSCC), with an emphasis on multi-omics and single-cell analysis to answer clinically relevant questions."
  },
  {
    "objectID": "pages/projects.html#grants-projects",
    "href": "pages/projects.html#grants-projects",
    "title": "Research",
    "section": "Grants & projects",
    "text": "Grants & projects\n\nPrognostic model for brain metastasis based on hematological markers (MZGC20230020)\n\nRole: PI\nMy contributions: End-to-end participation including data collection, model development, statistical analysis, and manuscript writing.\nPeriod / budget: 2023-06 to 2024-06; 20,000 RMB\n\n\n\nCAF-mediated EGFR-TKI resistance in HNSCC (2024ZYD0054)\n\nRole: First key researcher\nMy contributions: In vitro/in vivo experiments, model construction, and data analysis.\nPeriod / budget: 2024-09 to 2025-08; 300,000 RMB\n\n\n\nAI-driven neoantigen prediction & mRNA vaccine development for HNSCC (2025YFHZ0087)\n\nRole: Key participant (lead analyst)\nMy contributions: Data analysis, model development, and neoantigen prediction.\nPeriod / budget: 2025-01 to 2025-12; 200,000 RMB"
  },
  {
    "objectID": "pages/projects.html#links",
    "href": "pages/projects.html#links",
    "title": "Research",
    "section": "Links",
    "text": "Links\n\nGitHub: https://github.com/ZEN-LIU-1"
  }
]